Nemaura Medical (NMRD) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NMRD vs. AFIB, GMVDF, VRAYQ, VIVE, UTRS, MOTS, DRTSW, ANZUW, ATAKW, and BBLGWShould you be buying Nemaura Medical stock or one of its competitors? The main competitors of Nemaura Medical include Acutus Medical (AFIB), G Medical Innovations (GMVDF), ViewRay (VRAYQ), Viveve Medical (VIVE), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), and Bone Biologics (BBLGW). These companies are all part of the "medical equipment" industry. Nemaura Medical vs. Its Competitors Acutus Medical G Medical Innovations ViewRay Viveve Medical Minerva Surgical Motus GI Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Acutus Medical (NASDAQ:AFIB) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, media sentiment, earnings and profitability. Which has more risk & volatility, AFIB or NMRD? Acutus Medical has a beta of -0.67, suggesting that its share price is 167% less volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500. Do institutionals & insiders hold more shares of AFIB or NMRD? 56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 4.4% of Nemaura Medical shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by company insiders. Comparatively, 40.4% of Nemaura Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has stronger earnings & valuation, AFIB or NMRD? Nemaura Medical has lower revenue, but higher earnings than Acutus Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAcutus Medical$7.16M0.00-$81.66MN/AN/ANemaura Medical$3.02K0.00-$14.14M-$0.39N/A Is AFIB or NMRD more profitable? Nemaura Medical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Nemaura Medical's return on equity of 0.00% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Acutus Medical-272.74% -311.64% -11.57% Nemaura Medical N/A N/A N/A Does the media refer more to AFIB or NMRD? In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled Nemaura Medical'saverage media sentiment score. Company Overall Sentiment Acutus Medical Neutral Nemaura Medical Neutral SummaryNemaura Medical beats Acutus Medical on 6 of the 8 factors compared between the two stocks. Get Nemaura Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NMRD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart NMRD vs. The Competition Export to ExcelMetricNemaura MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$4K$74.52M$6.13B$10.58BDividend YieldN/AN/A5.65%4.69%P/E Ratio0.0011.0786.9626.71Price / SalesN/A35.70604.82131.77Price / CashN/A18.4137.9061.31Price / BookN/A15.8812.556.55Net Income-$14.14M-$26.39M$3.31B$277.50M Nemaura Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMRDNemaura Medical0.7314 of 5 starsN/AN/AN/A$4K$3.02K0.0040AFIBAcutus MedicalN/A$0.00flatN/A-99.6%$27K$7.16M0.00340Gap DownGMVDFG Medical InnovationsN/A$0.00flatN/A+0.0%$26K$4.42M0.0072VRAYQViewRayN/AN/AN/AN/A$18K$102.21M0.00300VIVEViveve MedicalN/A$0.00flatN/AN/A$2K$6.83M0.0070UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160MOTSMotus GI0.0208 of 5 starsN/AN/AN/A$1K$319K0.0030DRTSWAlpha Tau MedicalN/A$0.35+9.1%N/AN/A$0.00N/A0.0080Positive NewsShort Interest ↓ANZUWAnzu Special Acquisition Corp IN/A$0.04flatN/AN/A$0.00N/A0.002Gap UpATAKWAurora Technology AcquisitionN/A$0.02-11.8%N/A-54.5%$0.00N/A0.00N/AGap UpBBLGWBone BiologicsN/A$10.39-3.7%N/AN/A$0.00N/A0.002Gap Down Related Companies and Tools Related Companies AFIB Competitors GMVDF Competitors VRAYQ Competitors VIVE Competitors UTRS Competitors MOTS Competitors DRTSW Competitors ANZUW Competitors ATAKW Competitors BBLGW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NMRD) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nemaura Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nemaura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NMRD Stock Alerts